...
首页> 外文期刊>Molecular pharmaceutics >Formulation of Nonionic Surfactant Vesicles (NISV) Prepared by Microfluidics for Therapeutic Delivery of siRNA into Cancer Cells
【24h】

Formulation of Nonionic Surfactant Vesicles (NISV) Prepared by Microfluidics for Therapeutic Delivery of siRNA into Cancer Cells

机译:通过微流体制备的非离子表面活性剂囊泡(NISV)的制剂,用于治疗siRNA成癌细胞

获取原文
获取原文并翻译 | 示例
           

摘要

Small interfering RNAs (siRNA) have a broad potential as therapeutic agents to reversibly silence any target gene of interest. The clinical application of siRNA requires the use of safe and effective delivery systems. In this study, we investigated the use of nonionic surfactant vesicles (NISV) for the delivery of siRNA. Different types of NISV formulations were synthesized by microfluidic mixing and then evaluated for their physiochemical properties and cytotoxicity. The ability:of the NISV to carry and transfect siRNA targeting green fluorescent protein (GFP) into A549 that stably express GFP (copGFP-A549) was evaluated. Flow cytometry and Western blotting were used to study the GFP expression knockdown, and significant knockdown was observed as a result of siRNA delivery to the cells by NISV. This occurred in particular when using Tween 85, which was able to achieve more than 70% GFP knockdown. NISV were thus demonstrated to provide a promising and effective platform for therapeutic delivery of siRNA.
机译:小干扰RNA(siRNA)具有广泛的潜力作为治疗剂,可逆地沉默感兴趣的任何靶基因。 siRNA的临床应用需要使用安全有效的递送系统。在本研究中,我们研究了使用非离子表面活性剂囊泡(NISV)来递送siRNA。通过微流体混合合成不同类型的NISV制剂,然后评价其生理化学性质和细胞毒性。该能力:NISV携带和转染靶向绿色荧光蛋白(GFP)的siRNA,进入A549,评价稳定表达GFP(COPGFP-A549)。流式细胞术和Western印迹用于研究GFP表达敲低,并且由于尼苏氏细胞的SiRNA递送而观察到显着的敲低。这尤其发生在使用TWEEN 85时,其能够达到70%以上的GFP敲低。因此证明了NISV为siRNA的治疗递送提供了有希望和有效的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号